From Innovation to Standard of Care: Ablation-fit Leads the Way

A new review published in Radiology: Imaging Cancer emphasizes the pivotal role of ablation confirmation software in assessing the minimal ablative margin (MAM), now recognized as the strongest predictor of local tumor progression after percutaneous thermal ablation of several types of primary and secondary malignant liver tumors. 

Among the solutions reviewed, Ablation-fit is featured for its contribution to this clinical shift, designed to support interventional radiologists in making confident, intraoperative decisions. Powered by AI-driven segmentation and intensity-based deformable registration—the most accurate method available—Ablation-fit delivers fast, precise MAM quantification at the exact moment clinical action is possible. Its intraprocedural use enables immediate reablation when needed, improving outcomes and reducing uncertainty.

Evidence is growing: software-based MAM confirmation significantly increases the rate of complete (A0) ablations and helps define a new standard of care in interventional oncology.

We’re proud that Ablation-fit is at the forefront of this evolution.

👉 Paolucci et al., Quantitative Ablation Confirmation Methods in Percutaneous Thermal Ablation of Malignant Liver Tumors: Technical Insights, Clinical Evidence, and Future Outlook